Elevated Inflammatory Markers Combined With Positive Pneumococcal Urinary Antigen Are a Good Predictor of Pneumococcal Community-acquired Pneumonia in Children

被引:28
|
作者
Galetto-Lacour, Annick [1 ]
Alcoba, Gabriel [1 ]
Posfay-Barbe, Klara M. [2 ,3 ]
Cevey-Macherel, Manon [4 ]
Gehri, Mario [4 ]
Ochs, Martina M. [5 ]
Brookes, Roger H. [6 ]
Siegrist, Claire-Anne [2 ,3 ]
Gervaix, Alain [1 ]
机构
[1] Geneva Univ Hosp, Div Pediat Emergency Med, CH-1211 Geneva 14, Switzerland
[2] Geneva Univ Hosp, Dept Child & Adolescent Med, CH-1211 Geneva 14, Switzerland
[3] Univ Geneva, Geneva, Switzerland
[4] Univ Lausanne Hosp, Child & Adolescent Dept, Lausanne, Switzerland
[5] Sanofi Pasteur, Marcy Letoile, France
[6] Sanofi Pasteur, Toronto, ON, Canada
关键词
community-acquired pneumonia; pneumococcal infections; procalcitonin; C-reactive protein; pneumococcal urinary antigen; children; POLYMERASE-CHAIN-REACTION; C-REACTIVE PROTEIN; STREPTOCOCCUS-PNEUMONIAE; RESPIRATORY-INFECTION; SERUM PROCALCITONIN; ANTIBODY-RESPONSE; DIAGNOSIS; ETIOLOGY; BLOOD; BACTERIAL;
D O I
10.1097/INF.0b013e31829ba62a
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Our objective was to evaluate procalcitonin (PCT) and C-reactive protein (CRP) as predictors of a pneumococcal etiology in community-acquired pneumonia (CAP) in hospitalized children. Methods: Children requiring hospitalization for CAP were prospectively enrolled. The following indices were determined: antibodies against pneumococcal surface proteins (anti-PLY, pneumococcal histidine triad D, pneumococcal histidine triad E, LytB and pneumococcal choline-binding protein A), viral serology, nasopharyngeal cultures and polymerase chain reaction for 13 respiratory viruses, blood pneumococcal polymerase chain reaction, pneumococcal urinary antigen, PCT and CRP. Presumed pneumococcal CAP (P-CAP) was defined as a positive blood culture or polymerase chain reaction for Streptococcus pneumoniae or as a pneumococcal surface protein seroresponse (>= 2-fold increase). Results: Seventy-five patients were included from which 37 (49%) met the criteria of P-CAP. Elevated PCT and CRP values were strongly associated with P-CAP with odds ratios of 23 (95% confidence interval: 5-117) for PCT and 19 (95% confidence interval: 5-75) for CRP in multivariate analysis. The sensitivity was 94.4% for PCT (cutoff: 1.5 ng/mL) and 91.9% for CRP (cutoff: 100 mg/L). A value <= 0.5 ng/mL of PCT ruled out P-CAP in >90% of cases (negative likelihood ratio: 0.08). Conversely, a PCT value >= 1.5 ng/mL associated with a positive pneumococcal urinary antigen had a diagnostic probability for P-CAP of almost 80% (positive likelihood ratio: 4.59). Conclusions: PCT and CRP are reliable predictors of P-CAP. Low cutoff values of PCT allow identification of children at low risk of P-CAP. The association of elevated PCT or CRP with a positive pneumococcal urinary antigen is a strong predictor of P-CAP.
引用
收藏
页码:1175 / 1179
页数:5
相关论文
共 50 条
  • [31] DNA bacterial load in children with bacteremic pneumococcal community-acquired pneumonia
    S. Esposito
    A. Marchese
    A. E. Tozzi
    G. A. Rossi
    L. Da Dalt
    G. Bona
    C. Pelucchi
    G. C. Schito
    N. Principi
    European Journal of Clinical Microbiology & Infectious Diseases, 2013, 32 : 877 - 881
  • [32] Usefulness of Urinary Pneumococcal Antigen Testing in Patients with Community Acquired Pneumonia.
    Biswas, N.
    Cann, K.
    Shahidi, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [33] Antibiotic strategy in severe community-acquired pneumococcal pneumonia
    Le Bris-Tomczak, A.
    Bedos, J-P
    Billon, C.
    Samdjee, F.
    Le Monnier, A.
    MEDECINE ET MALADIES INFECTIEUSES, 2012, 42 (05): : 226 - 234
  • [34] Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia
    Endimiani, A
    Brigante, G
    Bettaccini, AA
    Luzzaro, F
    Grossi, P
    Toniolo, AQ
    BMC INFECTIOUS DISEASES, 2005, 5 (1)
  • [35] Decrease in drug resistance in pneumococcal community-acquired pneumonia
    Obando, Ignacio
    Arroyo, Luis
    Sanchez-Tatay, David
    CHEST, 2007, 132 (01) : 359 - 359
  • [36] Pneumococcal diagnosis and serotypes in childhood community-acquired pneumonia
    Elemraid, Mohamed A.
    Sails, Andrew D.
    Thomas, Matthew F.
    Rushton, Stephen P.
    Perry, John D.
    Eltringham, Gary J. A.
    Spencer, David A.
    Eastham, Katherine M.
    Hampton, Fiona
    Gennery, Andrew R.
    Clark, Julia E.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2013, 76 (02) : 129 - 132
  • [37] Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia
    Andrea Endimiani
    Gioconda Brigante
    Alessia A Bettaccini
    Francesco Luzzaro
    Paolo Grossi
    Antonio Q Toniolo
    BMC Infectious Diseases, 5
  • [38] Optimal therapy for severe pneumococcal community-acquired pneumonia
    Lujan, Manel
    Gallego, Miguel
    Rello, Jordi
    INTENSIVE CARE MEDICINE, 2006, 32 (07) : 971 - 980
  • [39] Prevention of Community-Acquired Pneumonia with Available Pneumococcal Vaccines
    Principi, Nicola
    Esposito, Susanna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (01)
  • [40] Optimal therapy for severe pneumococcal community-acquired pneumonia
    Manel Luján
    Miguel Gallego
    Jordi Rello
    Intensive Care Medicine, 2006, 32 : 971 - 980